Sarah Holmes is an Investment Analyst at The Cleveland Clinic Investment Office, where she focuses on commitments to Venture Capital and Private Equity funds as well as Buyout Co-Investments. She brings over five years of direct investing experience, with particular expertise in early-stage venture capital. While CCIO operates as a generalist platform, Sarah has developed deep knowledge in Biotech and Healthcare, extensively researching and underwriting managers across both venture and buyout strategies.
Sarah earned her MBA with a concentration in Finance from Babson College’s F.W. Olin Graduate School of Business. During her graduate studies, she completed internships with Underscore VC, the Babson College Endowment’s Private Equity team, and the University of Texas/Texas A&M Investment Management Company (UTIMCO). She holds a Bachelor of Arts degree from the University of Vermont.
